{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:50:59Z","timestamp":1791089459020,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"crossref","award":["TR1-01257"],"award-info":[{"award-number":["TR1-01257"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"crossref","award":["DR2-05415"],"award-info":[{"award-number":["DR2-05415"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UC Davis CTSC","award":["2P51RR000169-49"],"award-info":[{"award-number":["2P51RR000169-49"]}]},{"name":"CIRM Training Grant"},{"name":"CIRM Bridges program"},{"name":"NIH NHLBI","award":["1RO1 HL073256-01"],"award-info":[{"award-number":["1RO1 HL073256-01"]}]},{"name":"NIH NHLBI","award":["5P30AG010129-19"],"award-info":[{"award-number":["5P30AG010129-19"]}]},{"name":"NIH Director's transformative","award":["1R01GM099688"],"award-info":[{"award-number":["1R01GM099688"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.mcn.2011.12.001","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T00:09:00Z","timestamp":1323389340000},"page":"271-281","source":"Crossref","is-referenced-by-count":69,"title":["Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin"],"prefix":"10.1016","volume":"49","author":[{"given":"Scott D.","family":"Olson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Kambal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaela-Marie","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos","family":"Kalomoiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Cary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Nolta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2011.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/mt.2008.93","article-title":"In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors","volume":"16","author":"Bauer","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mcn.2011.12.001_bb0015","first-page":"3751","article-title":"Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones","volume":"38","author":"Biedler","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcn.2011.12.001_bb0020","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mcn.2011.12.001_bb0025","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddr137","article-title":"RNAi medicine for the brain: progresses and challenges","volume":"20","author":"Boudreau","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2011.12.001_bb0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2008070798","article-title":"Mesenchymal stem cell-derived microvesicles protect against acute tubular injury","volume":"20","author":"Bruno","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0166-0934(89)90132-8","article-title":"Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy","volume":"23","author":"Cornetta","year":"1989","journal-title":"J. Virol. Methods"},{"issue":"3","key":"10.1016\/j.mcn.2011.12.001_bb0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(04)00678-7","article-title":"Molecular medicine for the brain: silencing of disease genes with RNA interference","volume":"3","author":"Davidson","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mcn.2011.12.001_bb0045","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.mcn.2011.12.001_bb0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.gt.3302703","article-title":"The silent treatment: siRNAs as small molecule drugs","volume":"13","author":"Dykxhoorn","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.mcn.2011.12.001_bb0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cbf.1690","article-title":"The virtosome-a novel cytosolic informative entity and intercellular messenger","volume":"28","author":"Gahan","year":"2010","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.mcn.2011.12.001_bb0060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ceb.2008.03.005","article-title":"Intercellular transfer mediated by tunneling nanotubes","volume":"20","author":"Gerdes","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0065","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2011.12.001_bb0070","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2011.12.001_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-1119(01)00857-5","article-title":"Expression from cell type-specific enhancer-modified retroviral vectors after transduction: influence of marker gene stability","volume":"283","author":"Indraccolo","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.mcn.2011.12.001_bb0080","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/rme.10.72","article-title":"Mesenchymal stem cells for the treatment of neurodegenerative disease","volume":"5","author":"Joyce","year":"2010","journal-title":"Regen. Med."},{"key":"10.1016\/j.mcn.2011.12.001_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jxb\/erm176","article-title":"Long distance transport and movement of RNA through the phloem","volume":"59","author":"Kehr","year":"2008","journal-title":"J. Exp. Bot."},{"key":"10.1016\/j.mcn.2011.12.001_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","article-title":"CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches","volume":"153B","author":"Langbehn","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"2","key":"10.1016\/j.mcn.2011.12.001_bb0200","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","article-title":"A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference","volume":"217","author":"Lombardi","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2009.08.028","article-title":"HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells","volume":"290","author":"Matuskova","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mcn.2011.12.001_bb0100","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.2174\/138161209789649295","article-title":"RNAi applications in therapy development for neurodegenerative disease","volume":"15","author":"Maxwell","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mcn.2011.12.001_bb0105","series-title":"Establishment and transduction of primary human stromal\/ mesenchymal stem cell monolayers, Vol. Chapter 2","author":"Meyerrose","year":"2006"},{"key":"10.1016\/j.mcn.2011.12.001_bb0115","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1634\/stemcells.2008-0008","article-title":"Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease","volume":"26","author":"Meyerrose","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.mcn.2011.12.001_bb0185","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.addr.2010.09.013","article-title":"Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors","volume":"62","author":"Meyerrose","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mcn.2011.12.001_bb0120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bbrc.2004.05.021","article-title":"Adipogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice-including relationship of sex differences","volume":"319","author":"Ogawa","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.mcn.2011.12.001_bb0205","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1699-0463.1968.tb03502.x","article-title":"Long term culture of normal and neoplastic human glia","volume":"74","author":"Ponten","year":"1968","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.mcn.2011.12.001_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12015-008-9036-y","article-title":"The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles","volume":"4","author":"Quesenberry","year":"2008","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.mcn.2011.12.001_bb0135","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.leu.2404132","article-title":"Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.mcn.2011.12.001_bb0210","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/mt.2009.123","article-title":"Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease","volume":"17","author":"Rodriguez-Lebron","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mcn.2011.12.001_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0145","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1073\/pnas.052716199","article-title":"In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis","volume":"99","author":"Sekiya","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2011.12.001_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-52014-2.00001-X","article-title":"Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis","volume":"100","author":"Shannon","year":"2011","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","article-title":"Exosomes\u2013vesicular carriers for intercellular communication","volume":"21","author":"Simons","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0160","doi-asserted-by":"crossref","first-page":"e6219","DOI":"10.1371\/journal.pone.0006219","article-title":"Cellular microvesicle pathways can be targeted to transfer genetic information between non-immune cells","volume":"4","author":"Skinner","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2011.12.001_bb0165","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1073\/pnas.0510511103","article-title":"Mitochondrial transfer between cells can rescue aerobic respiration","volume":"103","author":"Spees","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.mcn.2011.12.001_bb0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00281-010-0234-8","article-title":"Exosomes\/microvesicles: mediators of cancer-associated immunosuppressive microenvironments","volume":"33","author":"Taylor","year":"2011","journal-title":"Semin. Immunopathol."},{"issue":"7","key":"10.1016\/j.mcn.2011.12.001_bb0215","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","article-title":"Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts","volume":"19","author":"van Bilsen","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mcn.2011.12.001_bb0175","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0960-9822(00)00157-3","article-title":"Plasmodesmata. Gateways for rapid information transfer","volume":"4","author":"Waigmann","year":"1994","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mcn.2011.12.001_bb0180","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbrc.2007.09.035","article-title":"Gap junction mediated transport of shRNA between human embryonic stem cells","volume":"363","author":"Wolvetang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.mcn.2011.12.001_bb0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","article-title":"Allele-specific silencing of mutant Huntington's disease gene","volume":"108","author":"Zhang","year":"2009","journal-title":"J. Neurochem."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104474311100265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104474311100265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T20:58:34Z","timestamp":1543352314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104474311100265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S104474311100265X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2011.12.001","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}